Catalyst Wire Dossier Catalyst Wire Dossier

Ozarelix

ozarelix · Spectrum Pharmaceuticals, Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ozarelix, covering 2021-10-05 to 2021-10-15. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate [Phase 2]

See pricing